255 related articles for article (PubMed ID: 18491405)
21. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
Chao C; Jacobsen SJ; Xu L; Wallner LP; Porter KR; Williams SG
BJU Int; 2013 May; 111(6):954-62. PubMed ID: 23464862
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort.
Jacobs EJ; Rodriguez C; Bain EB; Wang Y; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2213-7. PubMed ID: 17971518
[TBL] [Abstract][Full Text] [Related]
23. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
[TBL] [Abstract][Full Text] [Related]
24. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
[TBL] [Abstract][Full Text] [Related]
25. Minimal detection bias in the inverse association between statin drug use and advanced prostate cancer risk: a simulation study.
Mondul AM; Caffo B; Platz EA
Cancer Epidemiol; 2011 Aug; 35(4):e6-11. PubMed ID: 21167804
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes.
Marenzi G; Cosentino N; Werba JP; Tedesco CC; Veglia F; Bartorelli AL
Int J Cardiol; 2015 Mar; 183():47-53. PubMed ID: 25662053
[TBL] [Abstract][Full Text] [Related]
27. Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review.
Tan P; Zhang C; Wei SY; Tang Z; Gao L; Yang L; Wei Q
Asian J Androl; 2017; 19(6):666-671. PubMed ID: 27924788
[TBL] [Abstract][Full Text] [Related]
28. Review of recent evidence in support of a role for statins in the prevention of prostate cancer.
Hamilton RJ; Freedland SJ
Curr Opin Urol; 2008 May; 18(3):333-9. PubMed ID: 18382245
[TBL] [Abstract][Full Text] [Related]
29. Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.
Undela K; Gudala K; Malla S; Bansal D
J Neurol; 2013 Jan; 260(1):158-65. PubMed ID: 22820685
[TBL] [Abstract][Full Text] [Related]
30. Diabetes mellitus and risk of prostate cancer: a meta-analysis.
Bonovas S; Filioussi K; Tsantes A
Diabetologia; 2004 Jun; 47(6):1071-8. PubMed ID: 15164171
[TBL] [Abstract][Full Text] [Related]
31. Statin use is associated to a reduced risk of pancreatic cancer: A meta-analysis.
Archibugi L; Arcidiacono PG; Capurso G
Dig Liver Dis; 2019 Jan; 51(1):28-37. PubMed ID: 30314951
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.
Murtola TJ; Tammela TL; Lahtela J; Auvinen A
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2226-32. PubMed ID: 18006910
[TBL] [Abstract][Full Text] [Related]
33. Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies.
Lytras T; Nikolopoulos G; Bonovas S
World J Gastroenterol; 2014 Feb; 20(7):1858-70. PubMed ID: 24587664
[TBL] [Abstract][Full Text] [Related]
34. Statins and prostate cancer risk: a case-control study.
Shannon J; Tewoderos S; Garzotto M; Beer TM; Derenick R; Palma A; Farris PE
Am J Epidemiol; 2005 Aug; 162(4):318-25. PubMed ID: 16014776
[TBL] [Abstract][Full Text] [Related]
35. Statins and risk of cancer: a systematic review and metaanalysis.
Browning DR; Martin RM
Int J Cancer; 2007 Feb; 120(4):833-43. PubMed ID: 17131313
[TBL] [Abstract][Full Text] [Related]
36. Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies.
Zhang F; Yang Y; Skrip L; Hu D; Wang Y; Wong C; Qiu J; Lei H
Acta Diabetol; 2012 Dec; 49 Suppl 1():S235-46. PubMed ID: 23124624
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.
Murtola TJ; Tammela TL; Määttänen L; Huhtala H; Platz EA; Ala-Opas M; Stenman UH; Auvinen A
Int J Cancer; 2010 Oct; 127(7):1650-9. PubMed ID: 20073066
[TBL] [Abstract][Full Text] [Related]
38. Statins and primary liver cancer: a meta-analysis of observational studies.
Pradelli D; Soranna D; Scotti L; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G
Eur J Cancer Prev; 2013 May; 22(3):229-34. PubMed ID: 23010949
[TBL] [Abstract][Full Text] [Related]
39. Statin use and prostate cancer risk in a large population-based setting.
Boudreau DM; Yu O; Buist DS; Miglioretti DL
Cancer Causes Control; 2008 Sep; 19(7):767-74. PubMed ID: 18322813
[TBL] [Abstract][Full Text] [Related]
40. Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies.
Bansal D; Bhansali A; Kapil G; Undela K; Tiwari P
Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):151-8, S1. PubMed ID: 23032360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
